Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes | Zendy

AI Assistant Blog Pricing

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.